D Meshkov - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D Meshkov

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Terapevticheskii Arkhiv|October 26, 2022

[The prevalence of osteoarthritis and its association with geriatric syndromes in people over 65: data from the Russian epidemiological study EVKALIPT]A V Naumov, N M Vorobyeva, N O Khovasova, et al.

Terapevticheskii Arkhiv|May 24, 2024

[Real-world experience with netakimab in the treatment of spondyloarthritis]A D Meshkov, N M Vorobyeva, V S Ostapenko, et al.

Doklady. Biochemistry and Biophysics|July 13, 2024

Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort StudyE E Fedorinova, N M Bulanov, A D Meshkov, et al.

Frontiers in Medicine|June 11, 2026

Direct interleukin-6 inhibitor olokizumab in the treatment of polymyalgia rheumatica: a case seriesAlexey D Meshkov, Alexey L Maslyanskiy, Anton L Chudinov, et al.

Terapevticheskii Arkhiv|July 4, 2013

[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases]S V Moiseev, P I Novikov, E N Semenkova, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Terapevticheskii Arkhiv|October 26, 2022

[The prevalence of osteoarthritis and its association with geriatric syndromes in people over 65: data from the Russian epidemiological study EVKALIPT]A V Naumov, N M Vorobyeva, N O Khovasova, et al.

Terapevticheskii Arkhiv|May 24, 2024

[Real-world experience with netakimab in the treatment of spondyloarthritis]A D Meshkov, N M Vorobyeva, V S Ostapenko, et al.

Doklady. Biochemistry and Biophysics|July 13, 2024

Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort StudyE E Fedorinova, N M Bulanov, A D Meshkov, et al.

Frontiers in Medicine|June 11, 2026

Direct interleukin-6 inhibitor olokizumab in the treatment of polymyalgia rheumatica: a case seriesAlexey D Meshkov, Alexey L Maslyanskiy, Anton L Chudinov, et al.

Terapevticheskii Arkhiv|July 4, 2013

[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases]S V Moiseev, P I Novikov, E N Semenkova, et al.

Pageof 2